Accelerate to discover

Back to filter

Related topics

Intoducing cellenONE: The revolutionary Single Cell isolator

Cellenion

May 25, 2022

A revolutionary platform based on sciDROP PICO precision dispensing technology and coupled with advanced image...

Advances in Leukemia research using shear flow and Bioflux system

Fluxion Biosciences

May 24, 2022

Leukemia is a rare cancer with many subtypes. The production of abnormal leukocytes create disruptions in the immune...

Extracellular Vesicle Purity Enhanced by Gen 2 qEV Columns With Customised Proprietary Resin

IZON

May 4, 2022

Izon Science has announced the launch of Gen 2, the enhanced range of qEV columns for size-exclusion...

Why use Cytek Aurora?

Cytek Biosciences

May 3, 2022

A prodigy incorporating a unique combination of patent-pending innovative technologies that takes flow cytometry to the...

May 28, 2022

Introducing Celloger Mini Plus: Automated and compact Live cell imaging inside your incubator

Curiosis

Apr 11, 2022

We are happy to introduce new Celloger Mini Plus, automated live cell imaging system! Click the video below to find out...

CQ1 live-cell confocal system: revealing the pathophysiology of COVID-19 infection

Yokogawa

Mar 21, 2022

Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities...

In-vivo webinar: a versatile use of SPECT/CT in the development of theranostic tracers

MOLECUBES

Mar 9, 2022

Combining (preclinical) imaging and targeted therapy, is the basis of theranostics. In this webinar, Dr. Florea will...

May 28, 2022

Introducing IsoPlexis Single-Cell Natural Killer Panel

IsoPlexis

Mar 4, 2022

Because of their ability to kill tumour cells, NK cells are an attractive target in cancer immunotherapy, therapeutic...

Show all topics (10)

High throughput flow screening assays to profile cell-mediated killing

Sep 14, 2016

Traditional assays for monitoring cell-mediated killing are only capable of homogenous live/dead
readouts for an entire sample. IntelliCyt’s iQue Screener is a high throughput suspension screening
platform based on flow cytometry. The system can identify multiple cell types in solution and report on
multiple cell killing readouts, including cell viability and apoptosis. Here we demonstrate high
throughput flow assays for cell-mediated killing in examples using NK cells and chimeric antigen
receptor (CAR) T-cells. For the NK cell assay, NK92 cells were utilized as effector cells and Jurkat
cells were utilized as target cells. By labeling either target or effector cells with IntelliCyt’s MultiCyt FL4
Cell Proliferation and Encoder dye, both cell populations can be simultaneously monitored. Viability
was determined by cell membrane integrity and Caspase 3 activation for both Jurkat and NK92 cells,
and the specificity of the killing response was demonstrated using inhibitors of cell killing activity. In the
CAR T-cell assay, the efficacy of different CARs at targeting and killing a B-cell line (NALM-6) was
profiled with multiplex assays. In addition to cell encoding and live/dead analysis, cytokine responses
were evaluated using bead-based ELISA on the same analysis platform. These examples highlight the
robustness and flexibility of the iQue Screener for performing multiplexed screening assays for cell
mediated killing with greater contextual value.

Read more

Scientific paper
Application
Product news

Related technologies: HTP Screening

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

IntelliCyt

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey